Press release
Japan CRISPR-Cas9 Gene Editing Market Growth to Reach US$856.4 Million by 2033., R&D Expands Rapidly with Pharma-Biotech Collaborations & Gov't Funding (2026)
Japan CRISPR-Cas9 Gene Editing Market Size 2026
Japan's CRISPR-Cas9 gene editing market is poised to reached US$232.3 Million in 2024 and grow from US$268.5 Million in 2025 to US$856.4 Million by 2033 With (CAGR 15.6%), driven by pharma-biotech partnerships, government funding, and rare disease innovation. Takara Bio, Takeda, and Kyowa Kirin lead R&D initiatives, creating early investment and collaboration opportunities in regenerative medicine, stem cell therapy, and oncology.
Japan: Recent Industry Developments
✅ February 2026: Takara Bio advanced CRISPR-Cas9 platforms for precision gene editing in regenerative medicine and stem cell research.
✅ January 2026: RIKEN Center for Integrative Medical Sciences implemented CRISPR-based disease models to accelerate drug discovery for rare genetic disorders.
✅ December 2025: Kyowa Kirin collaborated with biotech startups to scale CRISPR-Cas9 therapeutics targeting hematological and oncology applications.
Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/japan-crispr-cas9-gene-editing-market?kb
Latest Mergers & Acquisitions 2026:
• Takeda Pharmaceutical enters CRISPR‐Cas9 R&D partnership with a domestic biotech startup to co‐develop gene‐editing therapeutics targeting rare genetic disorders (Jan 2026)
Top Japanese Key Players 2026:
Takeda Pharmaceutical Company Limited, DAIICHI SANKYO COMPANY, LIMITED, and Astellas Pharma Inc
Global life sciences leaders such as Thermo Fisher Scientific Inc., Merck KGaA, GenScript, and DH Life Sciences, LLC.
Partnerships with these leaders provide access to cutting-edge CRISPR IP and R&D networks.
Buy Now Secure comprehensive market data and competitor strategies for strategic decision-making:- https://www.datamintelligence.com/buy-now-page?report=japan-crispr-cas9-gene-editing-market?kb
Funding by Companies 2026:
• Government‐backed funding accelerates innovation - C4U Corporation secured significant non‐dilutive funding (USD 14 million) from Japan Agency for Medical Research and Development under a pharmaceutical startup support program to advance CRISPR‐based stem cell therapy R&D.
• Pharma & biotech R&D investment expands - Major Japanese pharma players such as Takeda Pharmaceutical, Daiichi Sankyo and Astellas actively integrate CRISPR‐Cas9 into therapeutic research pipelines through collaborations and internal projects.
• Private sector bolsters CRISPR tools & services - Companies like Takara Bio and global reagent providers (e.g., Thermo Fisher Scientific, Merck, GenScript) support gene‐editing research infrastructure with tools, reagents and services across Japan.
• Collaborations & licensing deals enhance capacity - International licensing and partnerships (e.g., ERS Genomics with Nippon Gene) enable broader access to CRISPR‐Cas9 IP and research reagents in Japan's gene editing research community.
• Academic-industry ties drive translational research - University and industry collaborations in genome editing (such as clinical research alliances) contribute to pre‐clinical and early‐stage development of CRISPR‐based therapies.
Growth Forecasting Projections 2026:
The Japan CRISPR-Cas9 Gene Editing Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Key Market Developments 2026:
✅ Feb 2026: Takara Bio advances CRISPR precision platforms for stem cell research.
✅ Jan 2026: RIKEN accelerates drug discovery using CRISPR-based disease models.
✅ Dec 2025: Kyowa Kirin partners with startups to scale CRISPR therapeutics in oncology.
Key Segmentations 2026:
pharmaceutical and biotechnology companies dominated the Japan CRISPR-Cas9 gene editing market, accounting for the largest revenue share of 46.6% in 2025
By Product: CRISPR-Cas9 Reagents, Cas9 Enzymes, Guide RNAs, Vectors & Plasmids, Buffers & Kits, Instruments & Systems, PCR Systems, Electroporators, Microinjection Systems, Flow Cytometers, Software & Platforms, Bioinformatics & Design Tools, Data Analysis Software
By Technology: CRISPR-Cas9 Nuclease Editing, CRISPR Interference (CRISPRi), CRISPR Activation (CRISPRa), Base Editing, Others
By End User: Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROs), Hospitals & Diagnostic Centers, Agricultural & Food Biotechnology Firms
By Application: Drug Discovery & Development, Functional Genomics, Gene Therapy Research, Cell Line Engineering, Disease Modeling, Agricultural Biotechnology, Diagnostics & Biomarker Development, Others
By Delivery Method: Viral Systems, Lentiviral, Adenoviral, Non-viral Systems, Electroporation, Lipid Nanoparticles, Physical Methods
By Disease Area: Oncology, Genetic Disorders, Infectious Diseases, Cardiovascular & Metabolic Disorders, Neurological Diseases, Others
Align insights with your investment or corporate strategy to unlock high-value CRISPR opportunities:- https://datamintelligence.com/customize/japan-crispr-cas9-gene-editing-market?kb
Growth Drivers & Strategic Outlook
✅ Government funding & non-dilutive grants accelerate clinical translation.
✅ Pharma-biotech collaborations expand pipeline readiness and reduce time-to-market.
✅ Increasing focus on rare diseases & regenerative medicine drives investment opportunities.
✅ Advanced CRISPR tools and services from private providers enhance research scalability.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?kb
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Japan CRISPR-Cas9 Gene Editing Market Growth to Reach US$856.4 Million by 2033., R&D Expands Rapidly with Pharma-Biotech Collaborations & Gov't Funding (2026) here
News-ID: 4418993 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Sugar Substitutes Market Poised for Rapid Expansion to USD 12.3 Billion by 2032, …
Leander, Texas -
The Sugar Substitutes Market reached USD 7.3 billion in 2022 and is projected to witness strong growth, potentially reaching USD 12.3 billion by 2030. The market is expected to grow at a CAGR of 6.8% during the forecast period 2025‐2032.
In 2026, the sugar substitutes sector is receiving increased attention due to rising health awareness, growing cases of diabetes and obesity, and the increasing demand for low-calorie and natural…
Microelectronic Medical Implants Market Set for Strong Growth to US$ 61.38 Billi …
The Microelectronic Medical Implants Market reached US$ 34.47 billion in 2024 and is expected to reach US$ 61.38 billion by 2033, growing at a robust CAGR of 6.5% during the forecast period 2026-2033.
The market is rapidly expanding due to the rising prevalence of chronic diseases like cardiovascular and neurological disorders, alongside advancements in micro-electro-mechanical systems (MEMS) and demand for minimally invasive technologies. This growth highlights a shift toward bioelectronic medicine,…
Environmental Technology Market Expected to Reach US$1,248.22 billion by 2032, G …
The global Environmental Technology market reached US$662.26 billion in 2024 and is expected to reach US$1,248.22 billion by 2032, expanding at a CAGR of 8.9% during the forecast period 2025-2032. The market is experiencing steady growth as governments, industries, and communities increasingly adopt technologies designed to reduce environmental impact and support sustainable development. Environmental technologies include solutions for waste management, water treatment, air pollution control, renewable energy integration, and environmental…
Future of Cystic Fibrosis (CF) Therapeutics Market 2025 | Drug Development, Pipe …
Market Size and Growth
cystic fibrosis (CF) therapeutics market reached US$ 9.22 billion in 2023, with a rise to US$ 10.60 billion in 2024, and is expected to reach US$ 35.09 billion by 2033, growing at a CAGR of 14.2% during the forecast period 2025-2033.
United States: Key Developments in CF Therapeutics
✅ Feb 2026: Toray Composite Materials America expanded production capacity to meet aerospace and defense demand.
✅ Jan 2026: Hexcel Corporation launched…
More Releases for CRISPR
CRISPR-based POC Diagnostics Market Set for Strong Expansion | • Illumina • …
➤ Global CRISPR-based POC Diagnostics Market Research Report (2026-2033)
The Worldwide "CRISPR-based POC Diagnostics Market" Research Report 2026 delivers a comprehensive, decision-ready analysis of the global CRISPR-based POC Diagnostics industry, offering clear insights into current market conditions and future growth potential. Developed using a robust research framework, the report combines validated data models, expert analysis, and real-world market intelligence to support strategic decision-making.
This study evaluates the complete market ecosystem, including industry…
Amerigo Scientific Unveils CRISPR/Cas Enzymes to Expand the CRISPR Toolbox
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, announced the release of a groundbreaking selection of CRISPR/Cas enzymes to its extensive life science portfolio, aimed at further expanding the vast potential of the CRISPR toolbox. This addition brings cutting-edge genetic editing tools to scientists and researchers in a variety of fields.
CRISPR/Cas (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated) technology revolutionized the…
CRISPR Technology Market - Gene Editing Redefined: Pioneering CRISPR Technology …
Newark, New Castle, USA: The "CRISPR Technology Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
CRISPR Technology Market: https://www.growthplusreports.com/report/crispr-technology-market/7632
This latest report researches the industry structure, sales,…
CRISPR And CRISPR-Associated (Cas) Genes Market Analysis & Trends - Industry For …
LOS ANGELES, United States: The research study presented in this report offers a complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global CRISPR And CRISPR-Associated (Cas) Genes market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global CRISPR And CRISPR-Associated (Cas) Genes market. The authors of the report have segmented…
CRISPR & Cas Genes Market Dynamic Growth Factors 2028 | CRISPR Therapeutics, Ast …
"CRISPR & Cas Genes Market" Report offers an in-depth analysis of the market size, share, SWOT Analysis, future progress expansion, industry growth, key development strategies and market trend dynamics which includes drivers, restraints, opportunities prevailing in the industry by product type, application, key manufacturers and key regions and countries.
It also offers advanced statistics as well as some business-driven information associated with the precise industry. It delivers an analytical investigation of the…
CRISPR and CRISPR-Associated (Cas) Genes Market 2022 | Detailed Report
According to Market Study Report, CRISPR and CRISPR-Associated (Cas) Genes Market provides a comprehensive analysis of the CRISPR and CRISPR-Associated (Cas) Genes Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=4240401
The report provides a comprehensive analysis of company profiles listed below:
-…
